You are here

Our science / Clinical Trials / Find a Trial / NCT00301431

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

Back to Search Print Save as PDF Bookmark Trial

NCT00301431

Last updated on February 21, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Huntsville, Alabama, 35801 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Fibromyalgia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Fibromyalgia according to 1990 American College of Rheumatology (ACR) criteria

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Other painful conditions that may make results difficult to interpret.

- Treatment with other drugs for fibromyalgia with 14 days of study start or during the
study.

NCT00301431
Pfizer
Terminated
Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Fibromyalgia
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia
NCT00830128
All Genders
18+
Years
Multiple Sites
Fibromyalgia
Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia
NCT00607256
All Genders
18+
Years
Multiple Sites
Fibromyalgia, Painful Diabetic Peripheral Neuropathy
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
NCT01280747
All Genders
18+
Years
Multiple Sites
Epilepsy, Neuropathic Pain, Fibromyalgia, Post-market Surveillance
Lyrica (Pregabalin) Korean Post Marketing Surveillance Study
NCT01220180
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now